Director, Biostatistics - Oncology BioPharma

Location United States
Discipline: Biometrics
Job type: Permanent
Salary: £Salary: $Strong salary, bonus, equity and supporting package.
Contact name: Daniel Cheetham

Contact email:
Contact phone: +1 (617) 982 1238
Job ref: 20498
Published: about 1 month ago
Expiry date: 15 April 2021

Location: Remote, USA​

  • An Oncology Biopharmaceutical company with a start-up feel, is seeking an experienced industry Biostatistician for a Director, Biostatistics opening

  • Report into the Head of Biometrics

  • High profile accountability for a significant portion of the company’s pipeline

  • Benefit from a culture that encourages collaboration, exploration and promotes a positive outlook

  • Small team with plenty of scope for growth

The Director will have significant influence on how the department utilises its technical capabilities, ensuring it remains at the forefront of statistical methodologies. They will work on projects ranging in complexity and will contribute to portfolio-level, strategy. The successful candidate will also act as a consultant to the wider business, offering statistical support to other teams across a broad range of topics within their expertise.


  • MS (with supplementary experience) or PhD in related discipline

  • Experience leading studies, programmes and/or compounds

  • Broad knowledge of statistical methodologies

  • Good SAS skills and other knowledge of other statistical software preferred

  • Demonstrable study leadership skills

  • Exceptional communication skills, both written and oral, and an ability to communicate complex statistical issues to a range of audience (statistical and not)

I manage a range of other permanent and contract positions for a broad portfolio of clients (Biotech, CRO and Pharma). If the above role isn’t for you but you’d nevertheless like to discuss your options in the market, I’d welcome a confidential discussion by phone or email. Contact Daniel Cheetham at (617) 982 1238.

Salary: $Strong salary, bonus, equity and supporting package.